Literature DB >> 26883455

P-glycoprotein inhibitors improve effective dose and time of pregabalin to inhibit intermittent cold stress-induced central pain.

Takehiro Mukae1, Wakako Fujita2, Hiroshi Ueda3.   

Abstract

Pregabalin (PGB) is a valuable therapeutic drug against chronic pain. Here we attempted to perform the combinatorial drug therapy with P-glycoprotein (P-gp) inhibitors to lower therapeutic dosage of PGB in the intermittent cold stress-induced fibromyalgia-like pain model. Single intracerebroventricular (i.c.v.) PGB injection exerted long-lasting anti-hyperalgesic effects for 72 h, while the effect of PGB given intraperitoneally (i.p.) disappeared within 3 h. Importantly, the pretreatment with P-gp inhibitors markedly prolonged the PGB (i.p.) effects, which lasted for 72 h. These results suggest that the combinatorial treatment with P-gp inhibitor enables the prolongation of dose-interval for PGB.
Copyright © 2016 The Authors. Production and hosting by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fibromyalgia; P-glycoprotein; Pregabalin

Mesh:

Substances:

Year:  2016        PMID: 26883455     DOI: 10.1016/j.jphs.2016.01.002

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  3 in total

1.  A pharmacokinetic drug-drug interaction study between pregabalin and tramadol in healthy volunteers.

Authors:  Soyoung Lee; Yun Kim; Janice Ji Sung Lee; Guangjin Im; Joo-Youn Cho; Jae-Yong Chung; Seonghae Yoon
Journal:  Eur J Clin Pharmacol       Date:  2018-08-22       Impact factor: 2.953

2.  LPA1 receptor involvement in fibromyalgia-like pain induced by intermittent psychological stress, empathy.

Authors:  Hiroshi Ueda; Hiroyuki Neyama
Journal:  Neurobiol Pain       Date:  2017-04-17

Review 3.  Potential Pharmacokinetic Drug-Drug Interactions between Cannabinoids and Drugs Used for Chronic Pain.

Authors:  Marta Vázquez; Natalia Guevara; Cecilia Maldonado; Paulo Cáceres Guido; Paula Schaiquevich
Journal:  Biomed Res Int       Date:  2020-08-13       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.